Cargando…
Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308366/ https://www.ncbi.nlm.nih.gov/pubmed/35870943 http://dx.doi.org/10.1186/s12964-022-00878-4 |
_version_ | 1784752969915301888 |
---|---|
author | Yuan, Zixu Yu, Xihu Chen, Wenle Chen, Daici Cai, Jian Jiang, Yingming Liu, Xiaoxia Wu, Zhijie Wang, Lei Grady, William M. Wang, Hui |
author_facet | Yuan, Zixu Yu, Xihu Chen, Wenle Chen, Daici Cai, Jian Jiang, Yingming Liu, Xiaoxia Wu, Zhijie Wang, Lei Grady, William M. Wang, Hui |
author_sort | Yuan, Zixu |
collection | PubMed |
description | BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome to screen out candidate epigenetic driver genes with transcription silencing. Methylated silencing HAND2 were identified and verified in large CRC cohort. The mechanism of HAND2 expression by promoter inhibition were clarified both in vitro and vivo assays. Cell biofunctional roles of HAND2 methylation was investigated in CRC cells. HAND2 reconstitution were constructed by lentivirus plasmid and tumor xenograft model of HAND2 were built subcutaneously. Genomic mRNA analysis by RNA-sequencing and subsequent GSEA analysis were performed to identify potential target of HAND2 and qPCR/WB was conducted to identify the results. RESULTS: We firstly reported high frequency of HAND2 methylation in promoter in CRC and hypermethylation was negatively correlated with expression silencing and leaded to poor survival in several CRC cohort patients. 5-Aza treatment to demethylated HAND2 could revert its expression in CRC cells. Functionally, HAND2 reconstitution can inhibit cell proliferation, invasion and migration in vitro. In tumor xenograft, HAND2 reconstruction significantly repressed tumor growth when compared to control vector. Thousands of aberrant expressed genes were observed in the heatmap of RNA-sequencing data. HAND2 reconstitution could bind to ERK and reduce its phosphorylation by CoIP assay. These above results showed HAND2 reconstitution perturbed the activation of MAPK/ERK signaling by reduction of ERK phosphorylation. CONCLUSIONS: HAND2 is one tumor suppressor by targeting ERK signaling and one potential epigenetic driver gene in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00878-4. |
format | Online Article Text |
id | pubmed-9308366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93083662022-07-24 Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer Yuan, Zixu Yu, Xihu Chen, Wenle Chen, Daici Cai, Jian Jiang, Yingming Liu, Xiaoxia Wu, Zhijie Wang, Lei Grady, William M. Wang, Hui Cell Commun Signal Research BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome to screen out candidate epigenetic driver genes with transcription silencing. Methylated silencing HAND2 were identified and verified in large CRC cohort. The mechanism of HAND2 expression by promoter inhibition were clarified both in vitro and vivo assays. Cell biofunctional roles of HAND2 methylation was investigated in CRC cells. HAND2 reconstitution were constructed by lentivirus plasmid and tumor xenograft model of HAND2 were built subcutaneously. Genomic mRNA analysis by RNA-sequencing and subsequent GSEA analysis were performed to identify potential target of HAND2 and qPCR/WB was conducted to identify the results. RESULTS: We firstly reported high frequency of HAND2 methylation in promoter in CRC and hypermethylation was negatively correlated with expression silencing and leaded to poor survival in several CRC cohort patients. 5-Aza treatment to demethylated HAND2 could revert its expression in CRC cells. Functionally, HAND2 reconstitution can inhibit cell proliferation, invasion and migration in vitro. In tumor xenograft, HAND2 reconstruction significantly repressed tumor growth when compared to control vector. Thousands of aberrant expressed genes were observed in the heatmap of RNA-sequencing data. HAND2 reconstitution could bind to ERK and reduce its phosphorylation by CoIP assay. These above results showed HAND2 reconstitution perturbed the activation of MAPK/ERK signaling by reduction of ERK phosphorylation. CONCLUSIONS: HAND2 is one tumor suppressor by targeting ERK signaling and one potential epigenetic driver gene in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00878-4. BioMed Central 2022-07-23 /pmc/articles/PMC9308366/ /pubmed/35870943 http://dx.doi.org/10.1186/s12964-022-00878-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yuan, Zixu Yu, Xihu Chen, Wenle Chen, Daici Cai, Jian Jiang, Yingming Liu, Xiaoxia Wu, Zhijie Wang, Lei Grady, William M. Wang, Hui Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title | Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title_full | Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title_fullStr | Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title_full_unstemmed | Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title_short | Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer |
title_sort | epigenetic silencing and tumor suppressor gene of hand2 by targeting erk signaling in colorectal cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308366/ https://www.ncbi.nlm.nih.gov/pubmed/35870943 http://dx.doi.org/10.1186/s12964-022-00878-4 |
work_keys_str_mv | AT yuanzixu epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT yuxihu epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT chenwenle epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT chendaici epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT caijian epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT jiangyingming epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT liuxiaoxia epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT wuzhijie epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT wanglei epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT gradywilliamm epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer AT wanghui epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer |